ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

Relative Outcomes of Planned Versus Unplanned Excision of Sarcomas i…

California Orthopaedic Association

S. Ahlquist

What's New: Basic Science and Oncology

Eastern Orthopaedic Association (EOA)

A. Levin

Bone and Soft Tissue Sarcoma: Why Referral Matters!

Western Orthopaedic Association

V. Lewis

Thank You For This Interesting Consult

Western Orthopaedic Association

C. Kelly

Case Reviews: Connecting a Leg Bone to the Humerus Bone to Treat Ped…

Cleveland Clinic Orthopaedic Case Studies

N. Mesko

Work Up of Soft Tissue Tumors

NYU Langone Orthopedic Webinar Series

H. Wolde-Semait

Metastatic Bone Disease: Evaluation and Initial Management

NYU Langone Orthopedic Webinar Series

T. Rapp

Bone and Soft Tissue Tumors: Work up and Biopsy Principles

NYU Langone Orthopedic Webinar Series

H. Wolde-Semait

Bone Tumors in the Skeletally Immature: Special Considerations

NYU Langone Orthopedic Webinar Series

K. Masrouha

EGFR-Targeted Fluorescence Guidance in Connective Tissue Oncology

Penn Medicine Abramson Cancer Center

E. Henderson

Surgical Treatment Options for Tenosynovial Giant Cell Tumor: A Look…

John Abraham

Medical Management of TGCT: How Has Pexidartinib Changed the Landsca…

John Abraham

Soft Tissue Reconstructive Procedures an Orthopaedic Oncologist Can …

Musculoskeletal Tumor Society

D. Adelman

Neuromodulation for Cancer Pain Medicine: Case Presentation - 72 Yea…

North American Neuromodulation Society (NANS)

H. Kalia, A. Gulati, J. Sindt, S. G. Pritzlaff, P. Patil

TGCT Overview: Considering Surgical Options and Pexidartinib

William Eward

Chondrosarcoma of the Manubrium and a Sternal Chondrasarcoma & Extra…

Cleveland Clinic Orthopaedic Case Studies

N. Mesko

Proximal Tibia Osteosarcoma with Transarticular Femoral Skip Metasta…

Eduardo Arbeo

E. Arbeo

Navigating CSF1 Inhibitor Use in TGCT Management: What Is the Curren…

R. Lor Randall

3D Printing in Orthopaedic Oncology: Where Are We Now?

CAOS Focus Group Oncology

s. dadia